Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

NATCO Pharma receives tentative FDA approval for generic (olaparib) tablets for Alembic US distribution
Small molecule, cancer, PARP inhibitor, ovarian cancer, generic drug - Read more

Biotronik Neuro acquires Soin Neuroscience spinal cord stimulation patent portfolio for next-generation chronic pain program
Acquisition, neurological, neuromodulation, chronic pain, medical devices - Read more

Kamada signs three-year $50M plasma supply agreement with unnamed biopharmaceutical company
Manufacturing agreement, plasma-derived therapies, rare disease, commercialization, milestone payments - Read more

Fangzhou, Novo Nordisk expand collaboration with China launch of once-weekly basal insulin/GLP-1 therapy Kyinsu
Commercialization, diabetes, AI/ML, digital health, small molecule, chronic disease management - Read more

Whether you’re working in genomics, imaging, or research, the key to innovation is fast, seamless access to your data–anywhere you need it. 

Qumulo Cloud Data Fabric unifies distributed data into a single global namespace, enabling teams to collaborate and access the same data from anywhere. 

Learn how Qumulo is putting infrastructure at the cutting edge of pharma and medical research. Explore the solution here.

4D Molecular Therapeutics' 4D-150 shows 87% treatment burden reduction in wet age-related macular degeneration Ph2b trial
Gene therapy, eye disease, AAV vector, wet age-related macular degeneration, anti-VEGF, single-dose intravitreal - Read more

Latigo Biotherapeutics' LTG-001 (Nav1.8 inhibitor) beats Vicodin in Ph2 trial for moderate-to-severe acute pain
Small molecule, pain, acute pain, non-opioid, postoperative pain - Read more

REGENXBIO presents 5-year Ph1/2a data for (surabgene lomparvovec) showing durability in wet age-related macular degeneration and diabetic retinopathy
Gene therapy, ophthalmology, AAV vector, wet AMD, diabetic retinopathy, anti-VEGF - Read more

Abbott beats Q2 expectations with strong device and diagnostic sales, raises full-year profit forecast
Diagnostics, oncology, financial, revenue impact - Read more

Latigo Biotherapeutics plans IPO to fund non-opioid Nav1.8 inhibitor pain pipeline
Pain management, small molecule, non-opioid, clinical-stage, Nav1.8 inhibitor - Read more

NuvOx Therapeutics files for $20M IPO, developing oxygen therapeutics targeting hypoxia-related diseases
Clinical-stage, oxygen therapeutics, neurology, oncology, rare disease - Read more

Sightera Biosciences raises €3M ($3.43M) pre-seed funding to advance AI-driven drug discovery platform
AI-driven, drug discovery, oncology, small molecule, preclinical - Read more

Scribe Therapeutics plans $96M IPO to advance lipid-lowering CRISPR genetic medicines
CRISPR, gene therapy, cardiovascular, clinical-stage, lipid-lowering - Read more

British Business Bank commits €25M ($28.6M) to EQT Life Sciences' EQT HE3 medtech and digital health fund
Life sciences, medtech, digital health, venture capital - Read more

BlossomHill Therapeutics files for IPO, advancing small molecule oncology pipeline including EGFR-targeting BH-30643
Oncology, small molecule, clinical-stage, non-small cell lung cancer, leukemia - Read more

UK biotech financing hits five-year high with £2.11B ($2.84B) equity investment in Q2 2026
Biotech sector, financial, investment, venture capital - Read more

Samsung Biologics launches all-cash tender offer to acquire PolyPeptide for ~CHF 1.46B ($1.81B), expanding peptide CDMO capabilities
Peptide therapeutics, metabolic disease, major transaction, strategic - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Kolon TissueGene's TG-C (TGF-β1) fails Ph3 co-primary endpoints in knee osteoarthritis trial
Cell-based gene therapy, musculoskeletal, chondrocytes, osteoarthritis, TGF-β1, intra-articular injection - Read more

Teva Pharmaceutical’s shares decline through July despite positive vitiligo drug results amid sector weakness
Small molecule, dermatology, financial, operational - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here